But this isnt possible according to muffintop
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
MSB
mesoblast limited
Add to My Watchlist
1.08%
!
$1.63

Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-14
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.63 |
Change
0.018(1.08%) |
Mkt cap ! $2.089B |
Open | High | Low | Value | Volume |
$1.63 | $1.67 | $1.61 | $4.510M | 2.752M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 63372 | $1.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.64 | 10769 | 34 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 62372 | 1.630 |
22 | 220893 | 1.625 |
19 | 293291 | 1.620 |
11 | 193515 | 1.615 |
16 | 126106 | 1.610 |
Price($) | Vol. | No. |
---|---|---|
1.635 | 13896 | 34 |
1.640 | 44582 | 17 |
1.645 | 113589 | 25 |
1.650 | 118471 | 15 |
1.655 | 111014 | 10 |
Last trade - 13.23pm 04/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online